A new study suggests that the weight loss drug can cause 'severe gastrointestinal problems'
Read Full Article
Tirzepatide, which is sold under the brand name Mounjaro, has been approved for use by diabetes patients in the UK an...
Read Full Article
The new drug is expected to ease supply problems in the longer term but will do nothing to counter the current spike ...
Read Full Article
Soaring demand for semaglutide injections thanks to their success as a weight-loss tool has resulted in a global supp...
Read Full Article
Pharmacists and scientists say there is a risk that the announcement of a third key use for the diabetes drug this we...
Read Full Article
